arxiv
PublishedMay 8, 2026 at 4:00 AM
▲bullish
Optimizing Social Utility in Sequential Experiments
Publisher summary· verbatim
arXiv:2605.06520v1 Announce Type: cross Abstract: Regulatory approval of products in high-stakes domains such as drug development requires statistical evidence of safety and efficacy through large-scale randomized controlled trials. However, the high financial cost of these trials may deter develope
Stay posted· Newsletter
A 5-min weekly brief — top movers, price watch, story of the week.
Discussion
No replies yet. Be first.
The Bubble Brief
WEEKLYRead regulatory-approval insights every Tuesday — top movers, new releases, story of the week.
Originally published on arxiv ↗